Syndrome of rapid-onset end-stage renal disease in two consecutive renal transplant recipients

Indian Journal of Nephrology

Volumn 23, Issue 3, 2013, Pages 222-225

  Onuigbo, M A ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic Health System Eau Claire   (United States)

Author keywords

Acute kidney injury; chronic kidney disease; end stage renal disease; renal transplant recipient

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION;

EID: 84878567671     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.111861     Document Type: Article

References (11)

1. Onuigbo MA. Syndrome of rapid-onset end-stage renal disease: A new unrecognized pattern of CKD progression to ESRD. Ren Fail 2010;32:954-8.
2. Onuigbo MA, Onuigbo N. The syndrome of rapid onset end-stage renal disease (SORO-ESRD): A new previously unrecognized pattern of CKD to ESRD progression-A call for rethinking and re-engineering of current paradigms in CKD management. In: Onuigbo MA, Onuigbo N, editors. Chronic Kidney Disease and RAAS Blockade: A New View of Renoprotection. London, England: Lambert Academic Publishing GmbH 11 and Co. KG; 2011. p. 188-236.
3. Onuigbo MA, Onuigbo NT. The syndrome of rapid onset end-stage renal disease (SORO-ESRD)-A new Mayo Clinic dialysis services experience, January 2010-February 2011. In: Di Iorio B, Heidland A, Onuigbo M, Ronco C, editors. Hemodialysis, When, How, Why. New York, NY: NOVA Science Publishers; 2012. p. 443-85.
4. Kelly KJ, Dominguez JH. Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol 2010;32:469-75.
5. Lo A. Strategies to prevent chronic allograft nephropathy in kidney transplantation: Focus on calcineurin inhibitors. Prog Transplant 2004;14:157-64.
6. Spinner ML, Saab G, Casabar E, Bowman LJ, Storch GA, Brennan DC. Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes. Transplantation 2010;90:412-8.
7. Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011;378:1428-37.
8. Lamattina J, Sollinger H, Becker Y, Mezrich J, Pirsch J, Odorico J. Long-term pancreatic allograft survival after renal retransplantation in prior simultaneous pancreas-kidney recipients. Am J Transplant 2012;12:937-46.
9. Arulkumaran N, West S, Chan K, Templeton M, Taube D, Brett SJ. Long-term renal function and survival of renal transplant recipients admitted to the intensive care unit. Clin Transplant 2012;26:E24-31.
10. Onuigbo MA. Reno-prevention vs. reno-protection: A critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET-A call for more circumspection. QJM 2009;102:155-67.
11. Onuigbo MA. Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients? Nephron Clin Pract 2011;118:c407-19.